News headlines about Nu Skin Enterprises (NYSE:NUS) have been trending somewhat positive this week, according to Accern Sentiment. Accern identifies negative and positive media coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Nu Skin Enterprises earned a coverage optimism score of 0.16 on Accern’s scale. Accern also gave headlines about the company an impact score of 46.9573771148253 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

Here are some of the headlines that may have impacted Accern Sentiment Analysis’s rankings:

Several analysts have weighed in on NUS shares. Zacks Investment Research raised shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating and set a $63.00 price objective on the stock in a research note on Wednesday, April 26th. ValuEngine raised shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research note on Friday, June 2nd. Pivotal Research reaffirmed a “buy” rating and set a $80.00 price objective (up from $65.00) on shares of Nu Skin Enterprises in a research note on Thursday, June 22nd. Sidoti cut shares of Nu Skin Enterprises from a “buy” rating to a “neutral” rating and set a $59.00 price objective on the stock. in a research note on Wednesday, April 26th. Finally, BidaskClub cut shares of Nu Skin Enterprises from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 31st. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and six have issued a buy rating to the company. Nu Skin Enterprises presently has a consensus rating of “Hold” and a consensus target price of $62.88.

Nu Skin Enterprises (NYSE:NUS) opened at 60.52 on Friday. The firm has a market capitalization of $3.20 billion, a price-to-earnings ratio of 20.24 and a beta of 1.31. The stock’s 50 day moving average is $62.87 and its 200-day moving average is $56.44. Nu Skin Enterprises has a 12 month low of $46.35 and a 12 month high of $66.04.

Nu Skin Enterprises (NYSE:NUS) last posted its earnings results on Wednesday, August 2nd. The company reported $0.77 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.69 by $0.08. Nu Skin Enterprises had a net margin of 7.53% and a return on equity of 24.14%. The firm had revenue of $550.10 million for the quarter, compared to analyst estimates of $548.09 million. During the same period in the previous year, the firm posted $0.79 EPS. The company’s revenue for the quarter was down 8.4% compared to the same quarter last year. Equities analysts anticipate that Nu Skin Enterprises will post $3.23 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 13th. Shareholders of record on Friday, August 25th will be issued a dividend of $0.36 per share. This represents a $1.44 dividend on an annualized basis and a yield of 2.38%. The ex-dividend date of this dividend is Wednesday, August 23rd. Nu Skin Enterprises’s payout ratio is 48.81%.

In other Nu Skin Enterprises news, General Counsel D Matthew Dorny sold 8,250 shares of the business’s stock in a transaction that occurred on Wednesday, July 5th. The shares were sold at an average price of $62.92, for a total transaction of $519,090.00. Following the sale, the general counsel now directly owns 46,730 shares of the company’s stock, valued at approximately $2,940,251.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, President Ryan S. Napierski sold 8,000 shares of the business’s stock in a transaction that occurred on Tuesday, July 25th. The stock was sold at an average price of $65.00, for a total transaction of $520,000.00. Following the sale, the president now directly owns 68,170 shares in the company, valued at $4,431,050. The disclosure for this sale can be found here. Insiders have sold a total of 24,250 shares of company stock worth $1,490,210 over the last three months. Insiders own 5.20% of the company’s stock.

TRADEMARK VIOLATION WARNING: This piece of content was reported by Daily Political and is the property of of Daily Political. If you are reading this piece of content on another publication, it was stolen and republished in violation of U.S. and international trademark and copyright laws. The correct version of this piece of content can be viewed at https://www.dailypolitical.com/2017/08/12/nu-skin-enterprises-nus-receives-daily-news-sentiment-rating-of-0-16.html.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.

Insider Buying and Selling by Quarter for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with MarketBeat.com's FREE daily email newsletter.